Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Cancer Research|November 1, 1990
Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patientsC F Stewart, R A Fleming, S G Arbuck, et al.Journal of Pharmaceutical Sciences|March 1, 1992
Factors affecting in vitro protein binding of etoposide in humansR A Fleming, W E Evans, S G Arbuck, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Changes in the clearance of total and unbound etoposide in patients with liver dysfunctionC F Stewart, S G Arbuck, R A Fleming, et al.Clinical Pharmacology and Therapeutics|October 1, 1991
Relation of systemic exposure to unbound etoposide and hematologic toxicityC F Stewart, S G Arbuck, R A Fleming, et al.American Journal of Hospital Pharmacy|November 1, 1989
Biotechnology products: new opportunities and responsibilities for the pharmacistC F Stewart, R A FlemingClinical Pharmacology and Therapeutics|January 1, 1989
Altered protein binding of etoposide in patients with cancerC F Stewart, J A Pieper, S G Arbuck, et al.American Journal of Hospital Pharmacy|June 1, 1990
Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injectionC F Stewart, R A FlemingInternational Journal of Pancreatology : Official Journal of the International Association of Pancreatology|August 1, 1990
Overview of chemotherapy for pancreatic cancerS G ArbuckAnnals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Taxol (paclitaxel): future directionsS G ArbuckPageof 18